Literature DB >> 6678193

Rheumatoid vasculitis: diagnostic and therapeutic decisions.

R S Panush, P Katz, S Longley, J Love, H Stanley.   

Abstract

Rheumatoid vasculitis is an uncommon but potentially catastrophic complication of RA. There are few extensive experiences recorded in the current literature and there is no consensus regarding the clinical features, laboratory findings, histologic pattern, prognosis, or appropriate management of this syndrome. We therefore surveyed 1,947 North American ARA members for their perceptions of rheumatoid vasculitis. Four hundred twenty-eight surveys were returned, of which 290 were suitable for analysis. The majority of respondents were within 10 years of fellowships and were evenly distributed among private practice, and part-time and full-time academic positions. The respondents saw 15-50 rheumatoid arthritis (RA) patients weekly and less than five RA vasculitis patients annually. The majority correctly diagnosed two actual and complex case histories from patients with and without autopsy-proven vasculitis. Respondents associated the following features most strongly with rheumatoid vasculitis - mononeuritis multiplex, digital gangrene, digital ischemic lesions, nailfold ischemic lesions, non-healing leg ulcers, palpable purpura, fingertip nodules, sensory neuropathy, scleromalacia perforans, high titer rheumatoid factor, positive visceral angiography, cryoglobulinemia, hypocomplementemia, circulating immune complexes, and histologic necrotizing vasculitis or vascular transmural neutrophilia. Digital lesions or sensory neuropathy alone were not viewed as portending an ominous prognosis by most respondents and would have been treated with nonsteroidal anti-inflammatory drugs, antimalarials, gold salts, or D-penicillamine. Other clinical manifestations considered as reflecting rheumatoid vasculitis (gangrene, mononeuritis multiplex, ulcers) were thought to worsen prognosis and would have been managed more often with corticosteroids, D-penicillamine, cytotoxic agents or plasmapheresis. Rheumatoid vasculitis is viewed as a heterogeneous group of syndromes with varying clinical and histopathologic features,which have different prognostic implications, and therefore should be managed differently. While these dta do not substitute for an extensive recorded series of patients, they provide useful information about community perceptions of an uncommon but difficult clinical problem. They identify the need for additional data to examine the validity of these attitudes.

Entities:  

Mesh:

Year:  1983        PMID: 6678193     DOI: 10.1007/bf02041550

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  48 in total

1.  Rheumatoid vasculitis.

Authors:  D Glass; N A Soter; P H Schur
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

2.  Nail studies in rheumatoid arthritis.

Authors:  E B HAMILTON
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

3.  The arteritis of rheumatoid arthritis.

Authors:  B CRUICKSHANK
Journal:  Ann Rheum Dis       Date:  1954-06       Impact factor: 19.103

4.  Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Authors:  M Weisman; N Zvaifler
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

5.  Focal lesions in skeletal muscles and peripheral nerves in rheumatoid arthritis and other conditions.

Authors:  B CRUICKSHANK
Journal:  J Pathol Bacteriol       Date:  1952-01

6.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

7.  Clinical background of rheumatoid vascular disease.

Authors:  M Wilkinson; W N Torrance
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

8.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis.

Authors:  R J Rapoport; F Kozin; S E Mackel; R E Jordon
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes.

Authors:  T Abel; B S Andrews; P H Cunningham; C M Brunner; J S Davis; D A Horwitz
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

View more
  3 in total

1.  Rheumatoid arthritis in Greece. Manifestations in different age groups.

Authors:  A P Andonopoulos; V Galanopoulou; A A Drosos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.

Authors:  A J Geirsson; G Sturfelt; L Truedsson
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

Review 3.  Arthropathy in Dermatology: A Comprehensive Review.

Authors:  Soumya Jagadeesan; Padmanabha Shenoy
Journal:  Indian Dermatol Online J       Date:  2017 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.